key: cord-0822372-01vjwqo7
authors: Li, Pengfei; Wang, Yining; Peppelenbosch, Maikel P.; Ma, Zhongren; Pan, Qiuwei
title: Systematically comparing COVID-19 with 2009 influenza pandemic for hospitalized patients
date: 2020-11-12
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.11.127
sha: 86a26e1ff79ace3b258dc26aed05a82d99fdd722
doc_id: 822372
cord_uid: 01vjwqo7

OBJECTIVES: This study aims to comprehensively compare the clinical features of hospitalized COVID-19 patients with hospitalized 2009 influenza pandemic patients. METHODS: We systematically searched Medline, Embase, Web of science, Cochrane CENTRAL and Google scholar to identify studies related to COVID-19 and 2009 influenza pandemic. The pooled incidence rates of clinical features were estimated using DerSimonian-Laird random-effects model with Freeman-Tukey double arcsine transformation method. RESULTS: We found the incidence rates of fever, cough, shortness of breath, sore throat, rhinorrhea, myalgia/muscle pain or vomiting were significantly higher in influenza compared to COVID-19 patients. The incidence rates of comorbidities including cardiovascular disease/ hypertension and diabetes were significantly higher in COVID-19 patients compared with influenza patients. In contrast, comorbidities such as asthma, chronic obstructive pulmonary disease and immunocompromised conditions were significantly more common in influenza compared to COVID-19 patients. Unexpectedly, the estimated rates of intensive care unit admission, treatment with extracorporeal membrane oxygenation, treatment with antibiotics and fatality were comparable between hospitalized COVID-19 and 2009 influenza pandemic patients. CONCLUSIONS: This study comprehensively estimated the differences and similarities of the clinical features and burdens of hospitalized COVID-19 and 2009 influenza pandemic patients. These knowledge will be important for better understanding the current COVID-19 pandemic.

The ongoing COVID-19 pandemic is spreading unprecedentedly, and the eventual outcome of this pandemic remains largely uncertain. The causative agent of COVID-19, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is highly contagious (Rothan and Byrareddy, 2020) . The clinical manifestations of SARS-CoV-2 infection range from asymptomatic to severe pneumonia, with some cases resulting in multiple organ failure or death (Adhikari et al., 2020) . The main reported symptoms include fever, cough, shortness of breath, myalgia, and fatigue . Death cases were primarily elderly patients with comorbidities such as hypertension, coronary heart disease and diabetes (Adhikari et al., 2020) .

It has been widely recognized that SARS-CoV-2 and influenza virus infections share substantial similarities in viral shedding, transmission dynamics and clinical features of respiratory illnesses (He et al., 2020 . Recent studies have attempted to revisit the historical experience of 1918 and 2009 influenza pandemics, in order to learn lessons for better understanding the current COVID-19 pandemic. These recent studies have revealed similarities and differences in transmissibility, epidemic wave, and mortality rate between COVID-19 and influenza pandemics (He et al., 2020 . To our knowledge, the published studies on comparison between influenza and COVID-19 pandemics are mainly focused on epidemiological features in the general population (Petersen et al., 2020, Viboud and Simonsen, 2012) . In fact, the J o u r n a l P r e -p r o o f 6 disease burden of both COVID-19 and influenza pandemics largely lies in the hospitalized patient population, which has not been systematically and comparatively studied.

There is scarcity of clinical data available on the 1918 influenza pandemic, but the latest influenza pandemic in 2009 has been extensively studied. In this study, we performed a systematic review and meta-analysis to comprehensively compare the burden and key clinical features of hospitalized patients between the 2009 influenza and COVID-19 pandemic.

J o u r n a l P r e -p r o o f

A systematic search was conducted in Medline, Embase, Web of science, Cochrane CENTRAL and Google scholar. Databases were searched for articles in English language from inception until 2030. All searches from database were performed by a biomedical information specialist of the medical library, with an exhaustive set of search terms to identify studies providing clinical features/outcomes of hospitalized patients for 2009 H1N1 influenza or COVID-19 pandemic. The full search strategies were provided in the supplementary file S1. This study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.

Studies were included if they met following criteria: i) studies which contained clinical characteristics of SARS-CoV-2 confirmed patients; ii) studies contained clinical characteristics of 2009 pandemic influenza H1N1 confirmed patients.

Studies were excluded if they met following criteria: i) studies belong to systematic review, meta-analysis, case reports, perspectives or conference abstracts; ii) animal coronavirus studies; iii) no primary data or incomplete data; iv) duplicate data; v) low quality studies. Detailed full-text review and data extraction was independently done by two investigators PL and YW. The investigators resolved discrepancies by jointly reviewing the study in question. If no consensus was reached, another reviewer (QP) would function as an arbiter to resolve disagreements.

Eligible studies were further screened to extract data. In case of multiple studies involving same population, the most comprehensive or most recent one would be included. The quality of studies was assessed using the Joanna Briggs Institute checklist for prevalence/incidence studies, which enabled assessment of included studies in relation to risk of bias, rigour, and transparency (Munn et al., 2020) .

Studies scoring 1-3 were defined as low quality, 4-6 as average quality, and 7-9 as high quality (Supplementary data Table 1 ).

After checking for consistency, the Metaprop module in the R-3.6.3 statistical software package was used for meta-analysis. A 95% confidence interval (95% CI) was estimated using Wilson score method, and pooled incidence rate was calculated by DerSimonian-Laird random-effects model with Freeman-Tukey double arcsine transformation method. Statistical heterogeneity was assessed using the Cochran Q statistics and I 2 statistics, with I 2 statistics categorized as low (I 2 =25%-50%), moderate (I 2 =50%-75%), high (I 2 >75%), or no statistical heterogeneity (I 2 =0%). A random-effect model would be used when the heterogeneity was higher than 50%. Mann-Whitney test (nonparametric test) was used to compare COVID-19 patient group and 2009 influenza pandemic patient group. P value <0.05 was considered as significant.

Database search yielded 21986 records after excluding replications. 113 studies with 36422 hospitalized COVID-19 patients and 84 studies with 23167 hospitalized influenza patients were finally included ( Figure 1 ). Patients of the two pandemics have similar sex distributions, with slightly over 50% as male gender.

The average age of hospitalized COVID-19 patients are 52 years (SD±16.93), which are much older than influenza patients (26 years in average, SD±15.57) ( Table 1) .

In hospitalized COVID-19 patients, the highest prevalent symptom is fever (72.08%, 95% CI 63.27-80.13; I 2 =99%), followed by cough (57.99%, 95% CI 53.32-62.59; I 2 = 97%), shortness of breath (32.89%, 95% CI 27.09-38.95; I 2 = 98%), fatigue (30.20%, 95% CI 24.75-35.93; I 2 = 96%), myalgia/muscle pain (18.97%, 95% CI 14.23-24.20; I 2 = 98%), diarrhea (10.16%, 95% CI 7.23-13.51; I 2 = 97%), sore throat (9.48%, 95% CI 7.47-11.69; I 2 = 88%), vomiting/nausea (8.67%, 95% CI 5.40-12.59; I 2 = 98%) and rhinorrhea (8.48%, 95% CI 6.02-11.28; (Figure 3 ; Supplementary data S21-29). Obesity is the most J o u r n a l P r e -p r o o f common comorbidity in influenza patients, with incidence rate of 17.89% (95% CI 13.40-22.86; I 2 = 98%), followed by asthma (16.09%, ; I 2 = 96%), cardiovascular disease/hypertension (13.11%, 95% CI 10.84-15.55, I 2 = 91%), diabetes (11.12%, 95% CI 9.39-12.97; I 2 = 92%), immunocompromised conditions (9.99%, 95% CI 8.30-11.82; I 2 = 92%), chronic obstructive pulmonary disease (COPD) (9.52%, 95% CI 7.09-12.24; I 2 = 94%), heart disease (8.66%, 95% CI 6.30-11.34; I 2 = 92%), cancer/malignancy (5.76%, 95% CI 4.09-7.67; I 2 = 88%) and renal disease (4.90%, 95% CI 3.86-6.05%; I 2 = 79%) (Figure 3 ; Supplementary data S30-38). Importantly, the estimated incidence rates of cardiovascular disease/ hypertension (28.76% vs. 13.11%) and diabetes (16.38% vs. 11.12%) are significantly higher in COVID-19 compared with influenza patients. In contrast, comorbidities such as asthma (16.09% vs. 8.42%), COPD (9.52% vs. 4.93%) and immunocompromised conditions (9.99% vs. 4.39%) are significantly more common in influenza compared to COVID-19 patients (p value<0.05; Table 2 ).

We comparatively analyzed clinical management for hospitalized COVID-19 and influenza patients. Because secondary bacterial infections are common after viral infection, and thus antibiotics are widely used in these patients. We found that the frequency of antibiotics treatment is similar between hospitalized COVID-19 compared to influenza patients are much older. This supports the notion that SARS-CoV-2 primarily causes severe diseases in elderly (Verity et al., 2020) , whereas H1N1 influenza severely affected younger population (Reed et al., 2014, Viboud and Simonsen, 2012) . Besides the common symptoms of respiratory infections, we found a proportion of patients from both pandemics have diarrhea and vomiting/nausea symptoms. Both SARS-CoV-2 and influenza viruses have been shown to effectively infect and replicate in the intestinal epithelium (Qu et al., 2012 , Xiao et al., 2020 , thereby causing gastrointestinal symptoms in patients (Gu et al., 2020 , Patel et al., 2010 . Consistent with previous studies reporting cardiovascular disease, hypertension and diabetes as risk factors of COVID-19 (Zhou et al., 2020) , we found a substantially high incidence rate of these comorbidities in COVID-19 patients.

In the general population, it becomes clear that the severity and mortality of SARS-CoV-2 infection are much higher than those of influenza infection (Ji et al., 2020 . This study revealed a completely different picture in hospitalized patient population. We found over 15% incidence rate of inpatients admitted to ICU in both H1N1 influenza and COVID-19 pandemics, suggesting comparable severity of disease prognosis in these hospitalized patients.

Consistently, hospitalized COVID-19 and 2009 influenza patients had similar death rates (12.94% vs. 9.63%).

Our study focused on the comparison between COVID-19 with 2009 pandemic influenza H1N1, but it would also be interesting to compare with seasonal flu caused by influenza A and B viruses. Hospitalized pandemic H1N1 patients in our analysis appear to have higher frequencies of fever, fatigue, vomiting, shortness of breath and diarrhea compared with hospitalized seasonal influenza patients (Zhang et al., 2020) . However, comorbidities including diabetes, COPD, immunocompromised status and heart disease seem more common in seasonal influenza patients compared with pandemic H1N1 patients (Mohammad et al., 2019) . Nevertheless, future studies are required to comprehensively, for example by systematic review and meta-analysis, compare COVID-19 with pandemic and seasonal influenza.

It has recently attracted attention of comparing COVID-19 with influenza or the infection of classical endemic coronaviruses in pediatric population. A comparison between children with COVID-19 and seasonal influenza showed no differences in hospitalization rates, ICU admission rates, and mechanical ventilator use (Song et al., 2020) . In infants below one year of age, there likely are no major differences in the clinical features, when comparing infections of SARS-CoV-2 with classical endemic coronaviruses or influenza virus (Li P. et al., 2020a , Li P. et al., 2020b , Vanhems et al., 2020 . Interestingly, some studies suggest that clinical manifestations of COVID-19 are even milder than influenza A in children under 5 years .

There are some limitations in this study. Firstly, the criteria for hospitalization may differ across different studies, therefore resulting in patient selection bias. Secondly, we were not able to estimate the incidence rate of extracorporeal 

All the authors declare that they have no conflict of interest.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. J o u r n a l P r e -p r o o f 

Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review

COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission

Comparing COVID-19 and the 1918-19 influenza pandemics in the United Kingdom

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Potential association between COVID-19 mortality and health-care resource availability

Systematically mapping clinical features of infections with classical endemic human coronaviruses

Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context

Comparison of hospitalized patients with pneumonia caused by COVID-19 and influenza A in children under 5 years

Clinical Characteristics of Influenza in Season

Chapter 5: Systematic reviews of prevalence and incidence

Pandemic (H1N1) 2009 influenza

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

COVID-19, SARS and MERS: are they closely related?

Human intestinal epithelial cells are susceptible to influenza virus subtype H9N2

Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children

Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Global mortality of 2009 pandemic influenza A H1N1

Evidence for Gastrointestinal Infection of SARS-CoV-2

Differentiation of COVID-19 from seasonal influenza: A multicenter comparative study

Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

We greatly thank Maarten F.M. Engel from the Medical Library, Erasmus MC-